pageInfo({
    time : "1261093537122"
  
	    , page : null
	  
	    , url : null
	  
	    , instrument : null
	  
	    , article : {
	        storyId : "UKN2536961620090526"
	        , headline : "UPDATE 3-MAP Pharma migraine drug hits all goals in study"
	        , keywords : "[Hot stocks, Equities, Pharmaceuticals - diversified, Pharmaceuticals (sub-industry), United States of America, Healthcare, Pharmaceuticals and biotechnology, Biotechnology, Pharmaceuticals - generic and speciality, United Kingdom, Western Europe, Europe, Economic news, EC, business/financial pages]"
	        , tickers : "[AZN.L, GSK.L, MRK.N, mx;GSKN, mx;MRK, pe;MRK, us;AZN, us;AZNC, us;AZND, us;DNDN, us;GLAX, us;GSK, us;MRK, us;VNDA, gb;GSK, gb;AZNX, gb;AZND, ch;MRK, de;DNR, de;DNRF, de;DNRS, de;DNRX, de;GS7, de;VM4, de;VM4F, de;VM4X, DNDN.O, fr;MRK, gb;AP47, gb;AZN, VNDA.O, MAPP.O]"
	    }
	    , channel : {
	        id : "54"
	        , name : "companyNews"
	        , title : "Company News"
	    }})